Abstract:In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for the detection and assessment of cognitive decline in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Neurophysiological biomarkers of AD derived from EEG and FDG-PET, once characterized and validated, would expand the set of existing diagnostic molecular biomarkers of AD pathology with associated biomarkers of disease progression and neural dysfunction. Since symptoms of AD often begin to appear later in life, successful identification of EEG-based biomarkers must account for age-related neurophysiological changes that occur even in healthy individuals. To this end, we collected EEG data from individuals with AD (n = 26), MCI (n = 53), and cognitively normal healthy controls stratified by age into three groups: 18–40 (n = 129), 40–60 (n = 62) and 60–90 (= 55) years old. For each participant, we computed power spectral density at each channel and spectral coherence between pairs of channels. Compared to age matched controls, in the AD group, we found increases in both spectral power and coherence at the slower frequencies (Delta, Theta). A smaller but significant increase in power of slow frequencies was observed for the MCI group, localized to temporal areas. These effects on slow frequency spectral power opposed that of normal aging observed by a decrease in the power of slow frequencies in our control groups. The AD group showed a significant decrease in the spectral power and coherence in the Alpha band consistent with the same effect in normal aging. However, the MCI group did not show any significant change in the Alpha band. Overall, Theta to Alpha ratio (TAR) provided the largest and most significant differences between the AD group and controls. However, differences in the MCI group remained small and localized. We proposed a novel method to quantify these small differences between Theta and Alpha bands’ power using empirically derived distributions of spectral power across the time domain as opposed to averaging power across time. We defined Power Distribution Distance Measure (PDDM) as a distance measure between probability distribution functions (pdf) of Theta and Alpha power. Compared to average TAR, using PDDF enhanced the statistical significance, the effect size, and the spatial distribution of significant effects in the MCI group. We designed classifiers for differentiating individual MCI and AD participants from age-matched controls. The classification performance measured by the area under ROC curve after cross-validation were AUC = 0.85 and AUC = 0.6, for AD and MCI classifiers, respectively. Posterior probability of AD, TAR, and the proposed PDDM measure were all significantly correlated with MMSE score and neuropsychological tests in the AD group.

A Promising Method to Distinguish Vascular Dementia from Alzheimer’s Disease with Standardized Low-Resolution Brain Electromagnetic Tomography and Quantitative EEG

The Significance Of Eeg Alpha Oscillation Spectral Power And Beta Oscillation Phase Synchronization For Diagnosing Probable Alzheimer Disease

Spectrum-specific Encephalography Standardized Low-Resolution Brain Electromagnetic Tomography Network and Gray Matter Correlations in Vascular Dementia Patients

The effect of aperiodic components in distinguishing Alzheimer's disease from frontotemporal dementia

Early Detection of Alzheimer’s Disease Using Non-invasive Near-Infrared Spectroscopy

The value of Event-related potentials and electroencephalorgraphy in the early stage of dementia

Fully Automated Discrimination of Alzheimer's Disease Using Resting-State Electroencephalography Signals.

Neural Biomarker Diagnosis and Prediction to Mild Cognitive Impairment and Alzheimer’s Disease Using EEG Technology

Differences in Multimodal Electroencephalogram and Clinical Correlations Between Early-Onset Alzheimer's Disease and Frontotemporal Dementia

Advanced qEEG analyses discriminate between dementia subtypes

Topological Network Analysis of Early Alzheimer's Disease Based on Resting-State EEG.

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment

Quantitative EEG in the Differential Diagnosis of Dementia Subtypes

Multiple Characteristics Analysis of Alzheimer’s Electroencephalogram by Power Spectral Density and Lempel–Ziv Complexity

Electroencephalography for Early Detection of Alzheimer’s Disease in Subjective Cognitive Decline

Electroencephalography can Ubiquitously Delineate the Brain Dysfunction of Neurodegenerative Dementia by Both Visual and Automatic Analysis Methods: A Preliminary Study

Resting EEG Discrimination of Early Stage Alzheimer’s Disease from Normal Aging Using Inter-Channel Coherence Network Graphs

Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease

Differentiating Between Alzheimer's Disease and Frontotemporal Dementia Based on the Resting-State Multilayer EEG Network.

Determination Of Vascular Dementia Brain In Distinct Frequency Bands With Whole Brain Functional Connectivity Patterns

High-Density EEG Signal Processing Based on Active-Source Reconstruction for Brain Network Analysis in Alzheimer’s Disease